{
    "id": "glp1_agonist_education_selectAll_v1",
    "type": "selectAll",
    "stem": "The nurse is providing education for a client starting a GLP-1 receptor agonist (e.g., semaglutide) for type 2 diabetes and weight management. Which information should the nurse include in the teaching?",
    "options": [
        {
            "id": "b",
            "text": "Administer the injection once daily at the same time each day."
        },
        {
            "id": "e",
            "text": "Discontinue the medication if you experience a single episode of vomiting."
        },
        {
            "id": "a",
            "text": "Report any new or worsening depression or suicidal thoughts immediately."
        },
        {
            "id": "d",
            "text": "Contact the healthcare provider for severe, persistent abdominal pain."
        },
        {
            "id": "c",
            "text": "Expect mild nausea and decreased appetite during the first few weeks."
        },
        {
            "id": "f",
            "text": "Rotate the injection site among the abdomen, thigh, or upper arm."
        }
    ],
    "correctOptionIds": [
        "a",
        "c",
        "d",
        "f"
    ],
    "pedagogy": {
        "bloomLevel": "apply",
        "cjmmStep": "takeAction",
        "nclexCategory": "Pharmacological and Parenteral Therapies",
        "difficulty": 3,
        "topicTags": [
            "Pharmacology",
            "Endocrine",
            "Client Education"
        ]
    },
    "rationale": {
        "correct": "GLP-1 agonists carry a risk for neuropsychiatric events, so reporting mood changes (Option A) is essential. Mild GI upset (Option C) is a common side effect during the dose-escalation phase. Severe, persistent abdominal pain (Option D) is a hallmark sign of pancreatitis, a known serious complication. Rotation of injection sites (Option F) is required for all subcutaneous medications to prevent lipodystrophy.",
        "incorrect": "Many GLP-1 agonists (like Ozempic/Semaglutide) are administered *once weekly*, not daily (Option B). While vomiting is a side effect, patients should not discontinue high-alert medications after a single episode without medical consultation (Option E); dose adjustments are usually preferred.",
        "answerBreakdown": [
            {
                "label": "A",
                "content": "In this specific NGN scenario, \"Administer the injection once daily at the same time each day.\" is incorrect as it introduces clinical risk or deviates from standard triage logic.",
                "isCorrect": false
            },
            {
                "label": "B",
                "content": "Choosing \"Discontinue the medication if you experience a single episode of vomiting.\" represents a misinterpretation of the gathered cues or a failure to prioritize physiological needs.",
                "isCorrect": false
            },
            {
                "label": "C",
                "content": "\"Report any new or worsening depression or suicidal thoughts immediately.\" represents a critical metric that must be monitored to evaluate the effectiveness of the current medical plan.",
                "isCorrect": true
            },
            {
                "label": "D",
                "content": "\"Contact the healthcare provider for severe, persistent abdominal pain.\" represents a critical metric that must be monitored to evaluate the effectiveness of the current medical plan.",
                "isCorrect": true
            },
            {
                "label": "E",
                "content": "\"Expect mild nausea and decreased appetite during the first few weeks.\" represents a critical metric that must be monitored to evaluate the effectiveness of the current medical plan.",
                "isCorrect": true
            },
            {
                "label": "F",
                "content": "\"Rotate the injection site among the abdomen, thigh, or upper arm.\" represents a critical metric that must be monitored to evaluate the effectiveness of the current medical plan.",
                "isCorrect": true
            }
        ],
        "clinicalPearls": [
            "GLP-1 agonists slow gastric emptying, which can affect the absorption of other oral medications."
        ],
        "questionTrap": {
            "trap": "The 'Daily vs Weekly' Confusion",
            "howToOvercome": "Pay close attention to the specific drug class. GLP-1s are famous for their weekly dosing, which is a major selling point for adherence."
        },
        "mnemonic": {
            "title": "G-L-P",
            "expansion": "Gastric slowing, Look for Pancreatitis, Psych monitoring."
        },
        "reviewUnits": [
            {
                "heading": "Incretin Mimetics",
                "body": "GLP-1 agonists mimic natural hormones to stimulate insulin and slow gastric emptying. Nursing priorities: GI tolerance, site rotation, and monitoring for pancreatitis.",
                "source": "Drug Guide for Nurses"
            }
        ]
    },
    "scoring": {
        "method": "polytomous",
        "maxPoints": 4
    }
}